|
|
|
Insider
Information: |
Mueller Peter |
Relationship: |
Director |
City: |
|
State: |
|
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
2 |
|
Direct
Shares |
311,837 |
|
Indirect Shares
|
25,571 |
|
|
Direct
Value |
$68,363,700 |
|
|
Indirect Value
|
$12,144,946 |
|
|
Total
Shares |
337,408 |
|
|
Total
Value |
$80,508,646 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
![](../../../Gifs/iconPlus.jpg) |
Vertex Pharmaceuticals Inc |
VRTX |
EVP, Global R&D, CSO |
2014-06-16 |
143,517 |
2014-06-16 |
25,571 |
Premium* |
![](../../../Gifs/iconPlus.jpg) |
Bioxcel Therapeutics Inc |
BTAI |
Director |
2019-08-23 |
168,320 |
2018-12-04 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
141 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 6 of 6
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
VRTX |
Vertex Pharmaceuticals In... |
EVP, Global R&D, CSO |
|
2014-02-05 |
4 |
A |
$0.01 |
$173 |
D/D |
17,250 |
158,750 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
CSO&EVP Drug Innov&Realization |
|
2006-11-16 |
4 |
AS |
$45.00 |
$795,870 |
D/D |
(17,686) |
85,226 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
CSO&EVP Drug Innov&Realization |
|
2006-11-16 |
4 |
OE |
$16.32 |
$288,636 |
D/D |
17,686 |
102,912 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Global R&D, CSO |
|
2011-09-20 |
4 |
OE |
$17.16 |
$441,390 |
D/D |
25,000 |
158,735 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Global R&D, CSO |
|
2011-09-20 |
4 |
AS |
$52.50 |
$1,312,500 |
D/D |
(25,000) |
133,735 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP Drug Innov.& Realiz, CSO |
|
2007-01-24 |
4 |
A |
$0.01 |
$321 |
D/D |
32,084 |
84,831 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
CSO&EVP Drug Innov&Realization |
|
2006-11-20 |
4 |
AS |
$45.00 |
$1,454,130 |
D/D |
(32,314) |
52,912 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Global R&D, CSO |
|
2011-04-11 |
4 |
AS |
$47.83 |
$1,921,020 |
D/D |
(40,000) |
133,735 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Global R&D, CSO |
|
2011-04-11 |
4 |
OE |
$10.41 |
$638,025 |
D/D |
40,000 |
173,735 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
CSO & SVP Drug Discovery |
|
2004-05-06 |
4 |
A |
$0.01 |
$650 |
D/D |
65,000 |
68,840 |
|
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Global R&D, CSO |
|
2012-05-07 |
4 |
OE |
$11.27 |
$1,346,025 |
D/D |
79,500 |
227,736 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Global R&D, CSO |
|
2012-05-07 |
4 |
AS |
$52.13 |
$4,216,085 |
D/D |
(79,500) |
148,236 |
0 |
- |
|
BTAI |
Bioxcel Therapeutics Inc |
Director |
|
2018-07-02 |
4 |
GA |
$0.00 |
$0 |
I/I |
90,000 |
90,000 |
0 |
- |
|
BTAI |
Bioxcel Therapeutics Inc |
Director |
|
2018-07-02 |
4 |
GD |
$0.00 |
$0 |
D/D |
90,000 |
119,795 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Global R&D, CSO |
|
2013-07-02 |
4 |
OE |
$16.32 |
$3,766,911 |
D/D |
122,300 |
266,700 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Global R&D, CSO |
|
2013-07-02 |
4 |
AS |
$78.94 |
$9,758,932 |
D/D |
(122,300) |
144,400 |
0 |
- |
|
141 Records found
|
|
Page 6 of 6 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|